Compiled and Produced by the Njardarson Group (The ... · I1 Humira I2 Revlimid I3 Enbrel I4 Opdivo...
1
I1 I2 I3 I4 I5 I6 I7 I8 I9 10 11 12 13 14 15 16 17 18 19 20 Humira Revlimid Enbrel Opdivo Keytruda Remicade Herceptin Avastin Mabthera Eylea Xarelto Eliquis Imbruvica Prevnar 13 Lantus Stelara Lyrica Neulasta Genvoya Prolia (Adalimumab) (Lenalidomide) (Etanercept) (Nivolumab) (Pembrolizumab) (Infliximab) (Trastuzumab) (Bevacizumab) (Rituximab) (Aflibercept) (Rivaroxaban) (Apixaban) (Ibrutinib) (PCV7 Vaccine) (Insulin Glargine) (Ustekinumab) (Pregabalin) (Pegfilgrastim) (Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide) (Denosumab) $20.484 Billion $9.685 Billion $7.935 Billion $7.567 Billion $7.171 Billion $7.085 Billion $7.052 Billion $6.917 Billion $6.858 Billion $6.654 Billion $6.58 Billion $6.438 Billion $6.205 Billion $5.803 Billion $5.779 Billion $5.251 Billion $5.216 Billion $4.683 Billion $4.624 Billion $4.467 Billion 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 Tecfidera Victoza Ibrance Gilenya Lucentis Januvia Xtandi Botox Soliris Triumeq Zytiga Mavyret Trulicity Advair Simponi Aria Gardasil 9 Humalog Truvada Xolair Invega Sustenna (Dimethyl Fumarate) (Liraglutide) (Palbociclib) (Fingolimod) (Ranibizumab) (Sitagliptin) (Enzalutamide) (Onabotulinumtoxin A) (Eculizumab) (Abacavir, Dolutegravir & Lamivudine) (Abiraterone Acetate) (Glecaprevir & Pibrentasvir) (Dulaglutide) (Salmeterol) (Golimumab) (HPV 9-Valent Vaccine) (Insulin Lispro) (Emtricitabine & Tenofovir Disoproxil) (Omalizumab) (Paliperidone Palmitate) $4.296 Billion $4.23 Billion $4.118 Billion $3.858 Billion $3.722 Billion $3.686 Billion $3.649 Billion $3.577 Billion $3.563 Billion $3.522 Billion $3.498 Billion $3.438 Billion $3.393 Billion $3.33 Billion $3.319 Billion $3.151 Billion $3.102 Billion $2.997 Billion $2.97 Billion $2.928 Billion 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Symbicort Fiasp Orencia Cosentyx Perjeta Spiriva Aranesp Nexium Ocrevus Copaxone Avonex & Plegridy Jardiance Velcade Entyvio Sprycel Janumet Lipitor Actemra Tivicay Jentadueto (Budesonide & Formoterol) (Insulin Aspart) (Abatacept) (Secukinumab) (Pertuzumab) (Tiotropium) (Darbepoetin Alfa) (Esomeprazole) (Ocrelizumab) (Glatiramer Acetate) (Interferon Beta-1A) (Empagliflozin) (Bortezomib) (Vedolizumab) (Dasatinib) (Metformin & Sitagliptin) (Atorvastatin) (Tocilizumab) (Dolutegravir) (Linagliptin) $2.926 Billion $2.903 Billion $2.859 Billion $2.837 Billion $2.801 Billion $2.726 Billion $2.418 Billion $2.400 Billion $2.377 Billion $2.366 Billion $2.363 Billion $2.309 Billion $2.283 Billion $2.276 Billion $2.275 Billion $2.228 Billion $2.207 Billion $2.182 Billion $2.18 Billion $2.154 Billion 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 Alimta Pomalyst Darzalex Votubia Epogen Epclusa Symtuza Tasigna Tysabri Aubagio Tagrisso Cialis Veramyst Dupixent Proquad Prograf Sensipar Xeljanz Spinraza Cimzia (Pemetrexed) (Pomalidomide) (Daratumumab) (Everolimus) (Epoetin Alfa) (Sofosbuvir & Velpatasvir) (Darunavir & Cobicistat) (Nilotinib) (Natalizumab) (Teriflunomide) (Osimertinib) (Tadalafil) (Fluticasone Furoate) (Dupilumab) (MMRV Vaccine) (Tacrolimus) (Cinacalcet) (Tofacitinib) (Nusinersen) (Certolizumab Pegol) $2.133 Billion $2.04 Billion $2.025 Billion $2.02 Billion $2.014 Billion $1.966 Billion $1.955 Billion $1.874 Billion $1.864 Billion $1.861 Billion $1.86 Billion $1.852 Billion $1.847 Billion $1.812 Billion $1.798 Billion $1.785 Billion $1.774 Billion $1.773 Billion $1.724 Billion $1.718 Billion 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 Levemir Pradaxa Lovenox Latuda Plavix Otezla Odefsey Boostrix Sandostatin Descovy Forteo Gleevec Farxiga Abilify Maintena Kogenate Haemophilia Crestor Novomix Synagis Liletta (Insulin Detemir) (Dabigatran Etexilate) (Enoxaparin) (Lurasidone) (Clopidogrel) (Apremilast) (Emtricitabine, Rilpivirine & Tenofovir Alafenamide) (dTap Vaccine) (Octreotide) (Emtricitabine & Tenofovir Alafenamide) (Teriparatide) (Imatinib) (Dapagliflozin) (Aripiprazole) (Antihemophilic Factor) (Human Coagulation Factor VIIa) (Rosuvastatin) (Biphasic Insulin Aspart) (Palivizumab) (Levonorgestrel) $1.679 Billion $1.679 Billion $1.655 Billion $1.648 Billion $1.627 Billion $1.608 Billion $1.598 Billion $1.592 Billion $1.587 Billion $1.581 Billion $1.576 Billion $1.561 Billion $1.514 Billion $1.491 Billion $1.479 Billion $1.436 Billion $1.433 Billion $1.422 Billion $1.391 Billion $1.342 Billion 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 Humulin Yervoy Brilinta TNKase Abraxane Myrbetriq Pulmicort Galvus Gadavist Orkambi Restasis E Keppra Benicar Vimpat Harvoni Opsumit Atripla Tresiba Biktarvy Novoseven (Insulin Isophane) (Ipilimumab) (Ticagrelor) (Alteplase & Tenecteplase) (Paclitaxel Protein Bound) (Mirabegron) (Budesonide) (Vildagliptin) (Ezetimibe) (Lumacaftor & Ivacaftor) (Cyclosporine) (Levetiracetam) (Olmesartan Medoxomil) (Lacosamide) (Ledipasvir & Sofosbuvir) (Macitentan) (Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumarate) (Insulin Degludec) (Bictegravir, Emtricitabine & Tenofovir Alafenamide) (Coagulation Factor VII) $1.331 Billion $1.33 Billion $1.321 Billion $1.297 Billion $1.292 Billion $1.287 Billion $1.286 Billion $1.284 Billion $1.271 Billion $1.262 Billion $1.262 Billion $1.254 Billion $1.242 Billion $1.241 Billion $1.222 Billion $1.215 Billion $1.206 Billion $1.205 Billion $1.184 Billion $1.182 Billion 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 Promacta Creon Juvederm Tafinlar Isentress Eligard Celecox Amlodin Acthar Jadenu Bexsero Chantix Sutent Shingrix Esbriet Faslodex Entresto Diovan HCT Kyprolis Kalydeco (Eltrombopag) (Pancrelipase) (Hyaluronic Acid) (Dabrafenib & Trametinib) (Raltegravir) (Leuprorelin) (Celecoxib) (Amlodipine) (Corticotropin) (Deferasirox) (Meningococcal Vaccine) (Varenicline) (Sunitinib) (Zoster Vaccine Recombinant) (Pirfenidone) (Fulvestrant) (Sacubitril & Valsartan) (Hydrochlorothiazide & Valsartan) (Carfilzomib) (Ivacaftor) $1.174 Billion $1.166 Billion $1.163 Billion $1.155 Billion $1.14 Billion $1.138 Billion $1.129 Billion $1.111 Billion $1.11 Billion $1.099 Billion $1.085 Billion $1.084 Billion $1.049 Billion $1.043 Billion $1.041 Billion $1.028 Billion $1.028 Billion $1.023 Billion $1.012 Billion $1.008 Billion 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 Exforge Kadcyla Ventolin Jakavi Somatuline Lumizyme Letairis Taltz Viagra Bridion Ofirmev Pneumovax 23 Nuvaring Lupron Rexulti Vesicare Lixiana Invokamet Alprolix Vectibix (Amlodipine & Valsartan) (Trastuzumab Emtansine) (Albuterol) (Ruxolitinib) (Lanreotide) (Alglucosidase Alfa) (Ambrisentan) (Ixekizumab) (Sildenafil) (Sugammadex) (Acetaminophen) (Pneumococcal Vaccine) (Ethinyl Estradiol & Etonogestrel) (Leuprolide) (Brexpiprazole) (Solifenacin) (Edoxaban) (Canagliflozin & Metformin Hcl) (Coagulation Factor IX) (Panitumumab) $1.002 Billion $989 Million $980 Million $977 Million $957 Million $949 Million $943 Million $937 Million $919 Million $917 Million $911 Million $907 Million $902 Million $892 Million $884 Million $884 Million $881 Million $881 Million $877 Million $872 Million 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 Lamictal Fabrazyme Lynparza Premarins Votrient Trintellix Cyramza Edurant Linzess Jynarque Nexavar Cerezyme Flovent Tecentriq Synthroid Symdeko Avodart Augmentin Ranexa Zoladex (Lamotrigine) (Agalsidase Beta) (Olaparib) (Conjugated Estrogens) (Pazopanib) (Vortioxetine) (Ramucirumab) (Rilpivirine) (Linaclotide) (Tolvaptan) (Sorafenib) (Imiglucerase) (Fluticasone Propionate) (Atezolizumab) (Levothyroxine) (Tezacaftor & Ivacaftor) (Dutasteride) (Amoxicillin & Clavulanate) (Ranolazine) (Goserelin) $865 Million $853 Million $834 Million $832 Million $828 Million $826 Million $821 Million $816 Million $816 Million $810 Million $805 Million $803 Million $791 Million $780 Million $776 Million $769 Million $761 Million $758 Million $758 Million $752 Million 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 Nucala Pulmozyme Nplate Baraclude Noxafil Risperdal Consta Aprovel Adempas Rotateq YAZ Tarceva Seloken Byetta Cymbalta Singulair Glucobay Nexplanon Fluarix Adalat Nexgard (Mepolizumab) (Dornase Alfa) (Romiplostim) (Entecavir) (Posaconazole) (Risperidone) (Irbesartan & Hydrochlorothiazide) (Riociguat) (Rotavirus Vaccine) (Drospirenone & Ethinyl Estradiol) (Erlotinib) (Metoprolol) (Exenatide) (Duloxetine) (Montelukast) (Acarbose) (Etonogestrel) (Influenza Vaccine) (Nifedipine) (Afoxolaner) $749 Million $746 Million $746 Million $744 Million $742 Million $737 Million $737 Million $731 Million $728 Million $722 Million $714 Million $712 Million $710 Million $708 Million $708 Million $704 Million $703 Million $696 Million $690 Million $689 Million Key Oncology Neurological Disorders Diabetes Cardiovascular Diseases Infecous Diseases Respiratory Disorders Immunology Blood Disorders Vaccine Sexual Health Rare Diseases Miscellaneous Immunology Oncology Immunology Oncology Oncology Autoimmune Disorders Oncology Oncology Oncology Ophthalmology Cardiovascular Diseases Cardiovascular Diseases Oncology Vaccine Diabetes Immunology Neurological Disorders Blood Disorders Infecous Diseases Oncology Neurological Disorders Diabetes Oncology Neurological Disorders Ophthalmology Diabetes Oncology Renal Disorders Blood Disorders Infecous Diseases Oncology Infecous Diseases Diabetes Respiratory Disorders Immunology Vaccine Diabetes Infecous Diseases Respiratory Disorders Neurological Disorders Respiratory Disorders Diabetes Immunology Immunology Oncology Respiratory Disorders Blood Disorders Gastrointesnal Disorders Neurological Disorders Neurological Disorders Neurological Disorders Diabetes Oncology An-Inflammatory Oncology Diabetes Cardiovascular Diseases Immunology Infecous Diseases Diabetes Oncology Oncology Oncology Oncology Blood Disorders Infecous Diseases Infecous Diseases Oncology Neurological Disorders Neurological Disorders Oncology Sexual Health Respiratory Disorders Dermatology Vaccine Immunology Hormonal Disorders Immunology Spinal Muscular Atrophy An-Inflammatory Diabetes Blood Disorders Blood Disorders Neurological Disorders Cardiovascular Diseases Dermatology Infecous Diseases Vaccine Oncology Infecous Diseases Bone And Joint Diseases Oncology Diabetes Neurological Disorders Rare Diseases Blood Disorders Cardiovascular Diseases Diabetes Respiratory Disorders Sexual Health Diabetes Oncology Cardiovascular Diseases Cardiovascular Diseases Oncology Renal Disorders Respiratory Disorders Diabetes Cardiovascular Diseases Respiratory Disorders Immunology Neurological Disorders Cardiovascular Diseases Neurological Disorders Infecous Diseases Cardiovascular Diseases Infecous Diseases Diabetes Infecous Diseases Blood Disorders Oncology Rare Diseases Dermatology Oncology Infecous Diseases Oncology An-Inflammatory Cardiovascular Diseases Autoimmune Disorders Oncology Vaccine Neurological Disorders Oncology Vaccine Autoimmune Disorders Oncology Cardiovascular Diseases Cardiovascular Diseases Oncology Respiratory Disorders Cardiovascular Diseases Oncology Respiratory Disorders Oncology Oncology Rare Diseases Cardiovascular Diseases Autoimmune Disorders Sexual Health Neurological Disorders An-Inflammatory Vaccine Sexual Health Oncology Neurological Disorders Renal Disorders Blood Disorders Diabetes Blood Disorders Oncology Neurological Disorders Rare Diseases Oncology Sexual Health Oncology Neurological Disorders Oncology Infecous Diseases Gastrointesnal Disorders Cardiovascular Diseases Oncology Rare Diseases Respiratory Disorders Oncology Hormonal Disorders Genec Disorders Renal Disorders An-Bacterial Cardiovascular Diseases Oncology Respiratory Disorders Rare Diseases Immunology Infecous Diseases An-Fungal Neurological Disorders Cardiovascular Diseases Cardiovascular Diseases Vaccine Sexual Health Oncology Cardiovascular Diseases Diabetes Neurological Disorders Respiratory Disorders Diabetes Sexual Health Vaccine Cardiovascular Diseases Parasic Infecons Top 200 Pharmaceutical Products by Retail Sales in 2018 Compiled and Produced by the Njardarson Group (The University of Arizona)
Transcript of Compiled and Produced by the Njardarson Group (The ... · I1 Humira I2 Revlimid I3 Enbrel I4 Opdivo...
I1 I2 I3 I4 I5 I6 I7 I8 I9 10 11 12 13 14 15 16 17 18 19 20Humira Revlimid Enbrel Opdivo Keytruda Remicade Herceptin Avastin Mabthera Eylea Xarelto Eliquis Imbruvica Prevnar 13 Lantus Stelara Lyrica Neulasta Genvoya Prolia(Adalimumab) (Lenalidomide) (Etanercept) (Nivolumab) (Pembrolizumab) (Infliximab) (Trastuzumab) (Bevacizumab) (Rituximab) (Aflibercept) (Rivaroxaban) (Apixaban) (Ibrutinib) (PCV7 Vaccine) (Insulin Glargine) (Ustekinumab) (Pregabalin) (Pegfilgrastim) (Elvitegravir, Cobicistat,
Emtricitabine, Tenofovir Alafenamide)(Denosumab)
$20.484 Billion $9.685 Billion $7.935 Billion $7.567 Billion $7.171 Billion $7.085 Billion $7.052 Billion $6.917 Billion $6.858 Billion $6.654 Billion $6.58 Billion $6.438 Billion $6.205 Billion $5.803 Billion $5.779 Billion $5.251 Billion $5.216 Billion $4.683 Billion $4.624 Billion $4.467 Billion
21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40Tecfidera Victoza Ibrance Gilenya Lucentis Januvia Xtandi Botox Soliris Triumeq Zytiga Mavyret Trulicity Advair Simponi Aria Gardasil 9 Humalog Truvada Xolair Invega Sustenna(Dimethyl Fumarate) (Liraglutide) (Palbociclib) (Fingolimod) (Ranibizumab) (Sitagliptin) (Enzalutamide) (Onabotulinumtoxin A) (Eculizumab) (Abacavir, Dolutegravir & Lamivudine) (Abiraterone Acetate) (Glecaprevir & Pibrentasvir) (Dulaglutide) (Salmeterol) (Golimumab) (HPV 9-Valent Vaccine) (Insulin Lispro) (Emtricitabine & Tenofovir Disoproxil) (Omalizumab) (Paliperidone Palmitate)
$4.296 Billion $4.23 Billion $4.118 Billion $3.858 Billion $3.722 Billion $3.686 Billion $3.649 Billion $3.577 Billion $3.563 Billion $3.522 Billion $3.498 Billion $3.438 Billion $3.393 Billion $3.33 Billion $3.319 Billion $3.151 Billion $3.102 Billion $2.997 Billion $2.97 Billion $2.928 Billion
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60Symbicort Fiasp Orencia Cosentyx Perjeta Spiriva Aranesp Nexium Ocrevus Copaxone Avonex & Plegridy Jardiance Velcade Entyvio Sprycel Janumet Lipitor Actemra Tivicay Jentadueto(Budesonide & Formoterol) (Insulin Aspart) (Abatacept) (Secukinumab) (Pertuzumab) (Tiotropium) (Darbepoetin Alfa) (Esomeprazole) (Ocrelizumab) (Glatiramer Acetate) (Interferon Beta-1A) (Empagliflozin) (Bortezomib) (Vedolizumab) (Dasatinib) (Metformin & Sitagliptin) (Atorvastatin) (Tocilizumab) (Dolutegravir) (Linagliptin)
$2.926 Billion $2.903 Billion $2.859 Billion $2.837 Billion $2.801 Billion $2.726 Billion $2.418 Billion $2.400 Billion $2.377 Billion $2.366 Billion $2.363 Billion $2.309 Billion $2.283 Billion $2.276 Billion $2.275 Billion $2.228 Billion $2.207 Billion $2.182 Billion $2.18 Billion $2.154 Billion
61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80Alimta Pomalyst Darzalex Votubia Epogen Epclusa Symtuza Tasigna Tysabri Aubagio Tagrisso Cialis Veramyst Dupixent Proquad Prograf Sensipar Xeljanz Spinraza Cimzia(Pemetrexed) (Pomalidomide) (Daratumumab) (Everolimus) (Epoetin Alfa) (Sofosbuvir & Velpatasvir) (Darunavir & Cobicistat) (Nilotinib) (Natalizumab) (Teriflunomide) (Osimertinib) (Tadalafil) (Fluticasone Furoate) (Dupilumab) (MMRV Vaccine) (Tacrolimus) (Cinacalcet) (Tofacitinib) (Nusinersen) (Certolizumab Pegol)
$2.133 Billion $2.04 Billion $2.025 Billion $2.02 Billion $2.014 Billion $1.966 Billion $1.955 Billion $1.874 Billion $1.864 Billion $1.861 Billion $1.86 Billion $1.852 Billion $1.847 Billion $1.812 Billion $1.798 Billion $1.785 Billion $1.774 Billion $1.773 Billion $1.724 Billion $1.718 Billion
81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100Levemir Pradaxa Lovenox Latuda Plavix Otezla Odefsey Boostrix Sandostatin Descovy Forteo Gleevec Farxiga Abilify Maintena Kogenate Haemophilia Crestor Novomix Synagis Liletta(Insulin Detemir) (Dabigatran Etexilate) (Enoxaparin) (Lurasidone) (Clopidogrel) (Apremilast) (Emtricitabine, Rilpivirine
& Tenofovir Alafenamide)(dTap Vaccine) (Octreotide) (Emtricitabine & Tenofovir Alafenamide) (Teriparatide) (Imatinib) (Dapagliflozin) (Aripiprazole) (Antihemophilic Factor) (Human Coagulation Factor VIIa) (Rosuvastatin) (Biphasic Insulin Aspart) (Palivizumab) (Levonorgestrel)
$1.679 Billion $1.679 Billion $1.655 Billion $1.648 Billion $1.627 Billion $1.608 Billion $1.598 Billion $1.592 Billion $1.587 Billion $1.581 Billion $1.576 Billion $1.561 Billion $1.514 Billion $1.491 Billion $1.479 Billion $1.436 Billion $1.433 Billion $1.422 Billion $1.391 Billion $1.342 Billion
101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120Humulin Yervoy Brilinta TNKase Abraxane Myrbetriq Pulmicort Galvus Gadavist Orkambi Restasis E Keppra Benicar Vimpat Harvoni Opsumit Atripla Tresiba Biktarvy Novoseven(Insulin Isophane) (Ipilimumab) (Ticagrelor) (Alteplase & Tenecteplase) (Paclitaxel Protein Bound) (Mirabegron) (Budesonide) (Vildagliptin) (Ezetimibe) (Lumacaftor & Ivacaftor) (Cyclosporine) (Levetiracetam) (Olmesartan Medoxomil) (Lacosamide) (Ledipasvir & Sofosbuvir) (Macitentan) (Efavirenz, Emtricitabine &
Tenofovir Disoproxil Fumarate)(Insulin Degludec) (Bictegravir, Emtricitabine
& Tenofovir Alafenamide)(Coagulation Factor VII)
$1.331 Billion $1.33 Billion $1.321 Billion $1.297 Billion $1.292 Billion $1.287 Billion $1.286 Billion $1.284 Billion $1.271 Billion $1.262 Billion $1.262 Billion $1.254 Billion $1.242 Billion $1.241 Billion $1.222 Billion $1.215 Billion $1.206 Billion $1.205 Billion $1.184 Billion $1.182 Billion
121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140Promacta Creon Juvederm Tafinlar Isentress Eligard Celecox Amlodin Acthar Jadenu Bexsero Chantix Sutent Shingrix Esbriet Faslodex Entresto Diovan HCT Kyprolis Kalydeco(Eltrombopag) (Pancrelipase) (Hyaluronic Acid) (Dabrafenib & Trametinib) (Raltegravir) (Leuprorelin) (Celecoxib) (Amlodipine) (Corticotropin) (Deferasirox) (Meningococcal Vaccine) (Varenicline) (Sunitinib) (Zoster Vaccine Recombinant) (Pirfenidone) (Fulvestrant) (Sacubitril & Valsartan) (Hydrochlorothiazide & Valsartan) (Carfilzomib) (Ivacaftor)
$1.174 Billion $1.166 Billion $1.163 Billion $1.155 Billion $1.14 Billion $1.138 Billion $1.129 Billion $1.111 Billion $1.11 Billion $1.099 Billion $1.085 Billion $1.084 Billion $1.049 Billion $1.043 Billion $1.041 Billion $1.028 Billion $1.028 Billion $1.023 Billion $1.012 Billion $1.008 Billion
141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160Exforge Kadcyla Ventolin Jakavi Somatuline Lumizyme Letairis Taltz Viagra Bridion Ofirmev Pneumovax 23 Nuvaring Lupron Rexulti Vesicare Lixiana Invokamet Alprolix Vectibix(Amlodipine & Valsartan) (Trastuzumab Emtansine) (Albuterol) (Ruxolitinib) (Lanreotide) (Alglucosidase Alfa) (Ambrisentan) (Ixekizumab) (Sildenafil) (Sugammadex) (Acetaminophen) (Pneumococcal Vaccine) (Ethinyl Estradiol & Etonogestrel) (Leuprolide) (Brexpiprazole) (Solifenacin) (Edoxaban) (Canagliflozin & Metformin Hcl) (Coagulation Factor IX) (Panitumumab)
$1.002 Billion $989 Million $980 Million $977 Million $957 Million $949 Million $943 Million $937 Million $919 Million $917 Million $911 Million $907 Million $902 Million $892 Million $884 Million $884 Million $881 Million $881 Million $877 Million $872 Million
161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180Lamictal Fabrazyme Lynparza Premarins Votrient Trintellix Cyramza Edurant Linzess Jynarque Nexavar Cerezyme Flovent Tecentriq Synthroid Symdeko Avodart Augmentin Ranexa Zoladex(Lamotrigine) (Agalsidase Beta) (Olaparib) (Conjugated Estrogens) (Pazopanib) (Vortioxetine) (Ramucirumab) (Rilpivirine) (Linaclotide) (Tolvaptan) (Sorafenib) (Imiglucerase) (Fluticasone Propionate) (Atezolizumab) (Levothyroxine) (Tezacaftor & Ivacaftor) (Dutasteride) (Amoxicillin & Clavulanate) (Ranolazine) (Goserelin)
$865 Million $853 Million $834 Million $832 Million $828 Million $826 Million $821 Million $816 Million $816 Million $810 Million $805 Million $803 Million $791 Million $780 Million $776 Million $769 Million $761 Million $758 Million $758 Million $752 Million
181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200Nucala Pulmozyme Nplate Baraclude Noxafil Risperdal Consta Aprovel Adempas Rotateq YAZ Tarceva Seloken Byetta Cymbalta Singulair Glucobay Nexplanon Fluarix Adalat Nexgard(Mepolizumab) (Dornase Alfa) (Romiplostim) (Entecavir) (Posaconazole) (Risperidone) (Irbesartan & Hydrochlorothiazide) (Riociguat) (Rotavirus Vaccine) (Drospirenone & Ethinyl Estradiol) (Erlotinib) (Metoprolol) (Exenatide) (Duloxetine) (Montelukast) (Acarbose) (Etonogestrel) (Influenza Vaccine) (Nifedipine) (Afoxolaner)
$749 Million $746 Million $746 Million $744 Million $742 Million $737 Million $737 Million $731 Million $728 Million $722 Million $714 Million $712 Million $710 Million $708 Million $708 Million $704 Million $703 Million $696 Million $690 Million $689 Million
Key Oncology Neurological Disorders Diabetes Cardiovascular Diseases Infectious Diseases Respiratory Disorders Immunology Blood Disorders Vaccine Sexual Health Rare Diseases Miscellaneous
Immunology Oncology Immunology Oncology Oncology Autoimmune Disorders Oncology Oncology Oncology Ophthalmology Cardiovascular Diseases Cardiovascular Diseases Oncology Vaccine Diabetes Immunology Neurological Disorders Blood Disorders Infectious Diseases Oncology
Neurological Disorders Diabetes Oncology Neurological Disorders Ophthalmology Diabetes Oncology Renal Disorders Blood Disorders Infectious Diseases Oncology Infectious Diseases Diabetes Respiratory Disorders Immunology Vaccine Diabetes Infectious Diseases Respiratory Disorders Neurological Disorders
Respiratory Disorders Diabetes Immunology Immunology Oncology Respiratory Disorders Blood Disorders Gastrointestinal Disorders Neurological Disorders Neurological Disorders Neurological Disorders Diabetes Oncology Anti-Inflammatory Oncology Diabetes Cardiovascular Diseases Immunology Infectious Diseases Diabetes
Oncology Oncology Oncology Oncology Blood Disorders Infectious Diseases Infectious Diseases Oncology Neurological Disorders Neurological Disorders Oncology Sexual Health Respiratory Disorders Dermatology Vaccine Immunology Hormonal Disorders Immunology Spinal Muscular Atrophy Anti-Inflammatory
Diabetes Blood Disorders Blood Disorders Neurological Disorders Cardiovascular Diseases Dermatology Infectious Diseases Vaccine Oncology Infectious Diseases Bone And Joint Diseases Oncology Diabetes Neurological Disorders Rare Diseases Blood Disorders Cardiovascular Diseases Diabetes Respiratory Disorders Sexual Health
Diabetes Oncology Cardiovascular Diseases Cardiovascular Diseases Oncology Renal Disorders Respiratory Disorders Diabetes Cardiovascular Diseases Respiratory Disorders Immunology Neurological Disorders Cardiovascular Diseases Neurological Disorders Infectious Diseases Cardiovascular Diseases Infectious Diseases Diabetes Infectious Diseases Blood Disorders
Oncology Rare Diseases Dermatology Oncology Infectious Diseases Oncology Anti-Inflammatory Cardiovascular Diseases Autoimmune Disorders Oncology Vaccine Neurological Disorders Oncology Vaccine Autoimmune Disorders Oncology Cardiovascular Diseases Cardiovascular Diseases Oncology Respiratory Disorders
Cardiovascular Diseases Oncology Respiratory Disorders Oncology Oncology Rare Diseases Cardiovascular Diseases Autoimmune Disorders Sexual Health Neurological Disorders Anti-Inflammatory Vaccine Sexual Health Oncology Neurological Disorders Renal Disorders Blood Disorders Diabetes Blood Disorders Oncology
Neurological Disorders Rare Diseases Oncology Sexual Health Oncology Neurological Disorders Oncology Infectious Diseases Gastrointestinal Disorders Cardiovascular Diseases Oncology Rare Diseases Respiratory Disorders Oncology Hormonal Disorders Genetic Disorders Renal Disorders Anti-Bacterial Cardiovascular Diseases Oncology
Respiratory Disorders Rare Diseases Immunology Infectious Diseases Anti-Fungal Neurological Disorders Cardiovascular Diseases Cardiovascular Diseases Vaccine Sexual Health Oncology Cardiovascular Diseases Diabetes Neurological Disorders Respiratory Disorders Diabetes Sexual Health Vaccine Cardiovascular Diseases Parasitic Infections
Top 200 Pharmaceutical Products by Retail Sales in 2018Compiled and Produced by the Njardarson Group (The University of Arizona)
